EUVIMEDEUVIMED entdecken
Crossref

Radiofrequency-responsive black phosphorus nanogel crosslinked with cisplatin for precise synergy in multi-modal tumor therapies

Can Hong, Yiming Liu, Dingwen Shi, Chao Liu, Shidong Zou, Mengqin Guo, Xingyu Chen, Chuansheng Zheng, Yanbing Zhao, Xiangliang Yang

Journal of Controlled Release · 2024

DOI: 10.1016/j.jconrel.2024.07.075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2024. Verfasst von Can Hong und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, 430074 …. Hauptthemen laut MEDLINE: Cisplatin, Phosphorus, Antineoplastic Agents, Mice, Inbred BALB C. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Defense Basic Scientific Research Program of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiofrequency-responsive nanoparticles (RFNPs) have drawn increasingly attentions as RF energy absorbing antenna to enhance antitumor efficacy of radiofrequency ablation (RFA). However, it remains a huge challenge for inorganic RFNPs to precisely synergize RFA with other antitumor modes in a clinically acceptable way on bio-safety and bio-compatibility. In this work, RF-responsive black phosphorus (BP) nanogel (BP-Pt@PNA) was successfully fabricated by crosslinking coordination of cisplatin with BP and temperature sensitive polymer PNA. BP-Pt@PNA exhibited strong RF-heating effect and RF-induced pulsatile release of cisplatin. Under RF irradiation, BP-Pt@PNA exhibited cytotoxic enhancement on 4T1 cells. By the synergistic effect of BP and cisplatin, BP-Pt@PNA achieved RF-stimulated systemic immune effect, thus induced enhance suppression on tumor growth and metastasis. Moreover, BP-Pt@PNA realized long-term drug retention in tumor and favorable embolization to tumor-feeding arteries. With high drug loading capacity and favorable bio-safety and bio-degradability, BP-Pt@PNA is expected as an ideal RFNP for precisely synergizing RFA with other antitumor modes in clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinPhosphorusAntineoplastic AgentsMice, Inbred BALB CNanogelsAnimalsCell Line, TumorFemaleRadio WavesMiceNeoplasmsPolyethyleneimineCombined Modality TherapyDrug LiberationCross-Linking ReagentsPolyethylene Glycols

Stichwörter der Autor:innen

Black phosphorusCancer chemotherapyHyperthermiaImmune effectRadiofrequency ablation

Substanzen

CisplatinPhosphorusAntineoplastic AgentsNanogelsPolyethyleneimineCross-Linking ReagentsPolyethylene Glycols

Autor:innen und Institutionen

  • National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, 430074 Wuhan, PR China.
  • Hubei Province Key Laboratory of Molecular Imaging, Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Hubei Province Key Laboratory of Molecular Imaging, Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.. Electronic address: hqzcsxh@sina.…
  • National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, 430074 Wuhan, PR China.; School of Biomedical Engineering, Hubei University o…
  • National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, 430074 Wuhan, PR China.; Key Laboratory of Molecular Biophysics of Ministry o…

Förderung

  • National Natural Science Foundation of China
  • National Defense Basic Scientific Research Program of China
  • National Key Research and Development Program of China

Zitieren

APA

Hong, C., Liu, Y., Shi, D., Liu, C., Zou, S., Guo, M., Chen, X., Zheng, C., Zhao, Y., & Yang, X. (2024). Radiofrequency-responsive black phosphorus nanogel crosslinked with cisplatin for precise synergy in multi-modal tumor therapies. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2024.07.075

Vancouver

Hong C, Liu Y, Shi D, Liu C, Zou S, Guo M, et al. Radiofrequency-responsive black phosphorus nanogel crosslinked with cisplatin for precise synergy in multi-modal tumor therapies. Journal of Controlled Release. 2024. doi:10.1016/j.jconrel.2024.07.075

BibTeX
@article{Hong2024,
  author = {Hong, Can and Liu, Yiming and Shi, Dingwen and Liu, Chao and Zou, Shidong and Guo, Mengqin and Chen, Xingyu and Zheng, Chuansheng and Zhao, Yanbing and Yang, Xiangliang},
  title = {Radiofrequency-responsive black phosphorus nanogel crosslinked with cisplatin for precise synergy in multi-modal tumor therapies},
  journal = {Journal of Controlled Release},
  year = {2024},
  doi = {10.1016/j.jconrel.2024.07.075}
}
Kostenlos starten →